MONEY

Inhibikase Therapeutics director Bellini acquires $2m in stock

Tomas Kauer - ModeratorTomas Kauer - Moderator
Oct 24, 2024 - 08:00
Inhibikase Therapeutics director Bellini acquires $2m in stock
Read More

Tags:

Previous Article

106 Questions You Can Ask Your Data with AI Chat 

Next Article

Mother sues AI chatbot company Character.AI, Google over son's suicide

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Tomas Kauer - Moderator
Tomas Kauer - Moderator

Related Posts

Morgan Stanley downgrades VAT Group stock as memory pricing environment weakens

Morgan Stanley downgrades VAT Group stock as memory pri...

Tomas Kauer - Mode... Sep 20, 2024

Spirit Airlines stock plunges to 52-week low at $2.38

Spirit Airlines stock plunges to 52-week low at $2.38

Tomas Kauer - Mode... Sep 24, 2024

Global stock index falls after record, oil turns higher

Global stock index falls after record, oil turns higher

Tomas Kauer - Mode... Oct 1, 2024